Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
Status:
Withdrawn
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Premature infants are at risk for developing bronchopulmonary dysplasia (BPD). L-citrulline
may decrease that risk, but we do not know the safety or dose of this drug for use in
premature babies. The purpose of this study is to determine the safety and optimal dose of
intravenous L-citrulline in premature infants.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center